Since the last influenza pandemic in 1918, the healthcare system has come a long way today. This is all the more evident from the swift reaction around the recent novel coronavirus outbreak. Even though the COVID-19 pandemic has taken the world by surprise, the global response to the virus outbreak has been prompt and relentless. Amid all this, genetic diagnostic is playing a critical role in identifying and mitigating the viral outbreak.
While CRISPR-based diagnostics development has been gaining traction over the past two years, the current pandemic is bridging the testing gap in the CRISPR revolution. With added impetus from the current pandemic, it may soon break through whatever barriers to commercialization remain. There is also a sharp rise in market demand for PCR, NGS, serology based rapid-test products. From the technological perspective, molecular diagnostics (MDx) and lateral flow assays (LAFs) are also dominating the genetic diagnostics market. And with the demand for quicker tests at community settings, the market is now moving into more point-of-care (POC) devices, including POC MDx and POC LFAs.
To this extent, many companies are bringing forth technology innovations for genetic diagnostics to meet the need for universal and massive testing. On that note, AI and blockchain are two critical technologies that are playing its part in revolutionizing the diagnostic processes. While AI is enabling healthcare professionals to rapidly test millions of DNA and RNA strands in the shortest time possible, blockchain is helping them secure these vast amounts of data and share it among the key stakeholders. Many software companies are also developing algorithms to train machine learning and deep learning to identify signs of aberrations in these data. These rapid changes are now prompting healthcare providers to improve and strengthen their core capabilities and establish strategic partnerships with the best-of-the-breed genetic diagnostic solution providers.
A wide variety of genetic diagnostics companies, at this juncture, are entering the industry with a set of advanced and integrated offerings. Healthcare Tech Outlook has compiled a list of the top 10 genetic diagnostic solution providers. Besides, the magazine also includes insights from thought leaders in the sector on the industry trends, best practices, latest innovations, and their advice for the aspiring CXOs.
We present to you Healthcare Tech Outlook’s, “Top 10 Genetic Diagnostics Companies – 2020.”
